Open access
Oct 2026
Atorvastatin-Curcuminoids Co-Treatment Suppresses ApoB Secretion and Alters Lipid and Glucose Homeostasis in HuH-7 Cells
Background/Objectives: Although statins are still the main treatment for dyslipidemia, differences in patient responses, residual cardiovascular risk, and treatment side effects highlight the need for additional methods. Curcumin has attracted considerable interest because of its reported cardioprotective and lipid- an...
A. Bakillah, Haidar A. Alsahoud, Abeer Al Otaibi et al.
· Pharmaceuticals · 0 citations